- Home
- APWC vs INKT Comparison
APWC vs INKT Comparison
Compare APWC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- INKT
- Stock Information
- Founded
- APWC 1996
- INKT 2017
- Country
- APWC Taiwan
- INKT United States
- Employees
- APWC N/A
- INKT N/A
- Industry
- APWC Telecommunications Equipment
- INKT Medicinal Chemicals and Botanical Products
- Sector
- APWC Industrials
- INKT Health Care
- Exchange
- APWC Nasdaq
- INKT Nasdaq
- Market Cap
- APWC 30.1M
- INKT 33.6M
- IPO Year
- APWC 1997
- INKT 2021
- Fundamental
- Price
- APWC $1.62
- INKT $7.70
- Analyst Decision
- APWC
- INKT Strong Buy
- Analyst Count
- APWC 0
- INKT 2
- Target Price
- APWC N/A
- INKT $37.50
- AVG Volume (30 Days)
- APWC 3.7K
- INKT 4.6K
- Earning Date
- APWC 03-31-2025
- INKT 05-13-2025
- Dividend Yield
- APWC N/A
- INKT N/A
- EPS Growth
- APWC N/A
- INKT N/A
- EPS
- APWC 0.17
- INKT N/A
- Revenue
- APWC $472,672,000.00
- INKT N/A
- Revenue This Year
- APWC N/A
- INKT N/A
- Revenue Next Year
- APWC N/A
- INKT N/A
- P/E Ratio
- APWC $9.17
- INKT N/A
- Revenue Growth
- APWC 11.02
- INKT N/A
- 52 Week Low
- APWC $1.24
- INKT $4.56
- 52 Week High
- APWC $2.02
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- APWC 54.52
- INKT 45.84
- Support Level
- APWC $1.55
- INKT $7.23
- Resistance Level
- APWC $1.65
- INKT $7.68
- Average True Range (ATR)
- APWC 0.08
- INKT 0.51
- MACD
- APWC 0.01
- INKT -0.02
- Stochastic Oscillator
- APWC 75.00
- INKT 34.37
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.